2021 SEP 23 (NewsRx) - By a News Reporter-Staff News Editor at Disease Prevention Daily - According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by the inventors CHATILA, Talal Amine (Belmont, MA, US); HARB, Hani (Brookline, MA, US); MASSOUD, Amir (Tehran, IR); XIA, Mingcan (Boston, MA, US), filed on March 15, 2019, was made available online on September 9, 2021. The assignee for this patent application is The Chidlren's Medical Center Corporation (Boston, Massachusetts, United States). Reporters obtained the following quote from the background information supplied by the inventors: "Exposure to traffic-related particulate matter (PM) promotes asthma and allergic diseases. However, the precise cellular and molecular mechanisms by which PM exposure acts to mediate these effects remain unclear. An understanding of cellular targets and signaling pathways critical for the augmentation of allergic airway inflammation induced by ambient ultra fine particles (UFP) is essential for developing therapeutics to treat or prevent asthma and allergic diseases."
展开▼
